Corrigendum to "Effect of disease duration on dose-response of inhaled budesonide in asthma" (DOI:10.1016/j.rmed.2007.12.029);Effect of disease duration on dose-response of inhaled budesonide in asthma

Respiratory Medicine

Volumn 102, Issue 7, 2008, Pages 1065-1072

  Selroos, Olof ^a,b  

^a Mjolbolsta Hospital   (Finland)

^b Semeco   (Sweden)

Author keywords

Asthma; Budesonide; Disease duration; Dose response; FEV1; Peak expiratory flow rate; Reliever medication; Symptoms

Indexed keywords

BUDESONIDE; HISTAMINE; PLACEBO;

ADULT; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OTALGIA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SHOULDER PAIN; SORE THROAT; TREMOR; UPPER RESPIRATORY TRACT INFECTION;

EID: 44749086576     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.021     Document Type: Erratum

References (28)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Available from: 〈http://www.ginasthma.org〉; 2006.
2. Haahtela T., Järvinen M., Kava T., et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331 (1994) 700-705
3. Selroos O., Pietinalho A., Löfroos A.-B., et al. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108 (1995) 1228-1234
4. Selroos O., Löfroos A.-B., Pietinalho A., et al. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med 98 (2004) 254-262
5. Haahtela T., Tamminen K., Malmberg L.P., et al. Follow-up results 10 years after early intervention with budesonide or terbutaline in mild persistent asthma. Eur Respir J 28 Suppl. 50 (2006) 667s
6. Asthma programme in Finland 1994-2004, with introduction Haahtela T, Laitinen LA. Clin Exp Allergy 1996;26:1-24.
7. Haahtela T., Tuomisto L.E., Pietinalho A., et al. A 10 year asthma programme in Finland: major change for the better. Thorax 61 (2006) 663-670
8. van der Molen T., and Kerstjens H.A.M. Starting inhaled corticosteroids in asthma: when, how high, and how long. Eur Respir J 15 (2000) 3-4
9. Powell H., and Gibson P.G. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. Thorax 59 (2004) 1041-1045
10. Kraan J., Koeter G.H., van der Mark T.W., et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 137 (1988) 44-48
11. Postma DS, Kerstjens HA, Koeter GH. In: Postma DS, Gerritsen JN, editors. Long-term intervention in disease outcome. Assen: Bronchitis V. van Gorcum; 1994. p. 253-66.
12. Shapiro G., Bronsky E.A., LaForce C.F., et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 132 (1998) 976-982
13. Busse W.W., Chervinsky P., Condemi J., et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 102 (1998) 457-463
14. Miyamoto T., Takahashi T., Nakajima S., et al. A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Respirology 5 (2000) 247-256
15. Bousquet J., Ben-Joseph R., Messonnier M., Alemao E., and Gould A.L. A meta-analysis of the dose-response relationships of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 24 (2002) 1-20
16. Boe J., Rosenhall L., Alton M., et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 44 (1989) 349-355
17. van der Molen T., Meyboom-de Jong B., Muldur H.H., et al. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med 158 (1998) 121-125
18. Gershman N.H., Wong H.H., Liu J.T., et al. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J 15 (2000) 11-18
19. Selroos O. Some aspects on comparative efficacy studies with inhaled corticosteroids in asthma. Curr Drug Ther 2 (2007) 57-74
20. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
21. Sovijärvi A.R.A., Malmberg P., Reinikainen K., et al. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Chest 104 (1993) 164-170
22. Astman diagnostiikka ja hoito, Käypä hoito suositus (Diagnosis and treatment of asthma, evidence based current care guideline) Duodecim 2000;116:2568-94. Updated 2006 [in Finnish].
23. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., et al. Low dose inhaled budesonide and formoterol in mild persistent asthma. The OPTIMA randomized trial. Am J Respir Crit Care Med 164 (2001) 1392-1397
24. Agertoft L., and Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88 (1994) 373-381
25. Turpeinen M, Nikander K, Pelkonen AS, et al. Daily versus as-needed inhaled corticosteroid for mild persistent asthma. Arch Dis Child [published online July 18, 2007].
26. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 (2006) 1985-1997
27. Boushey H.A., Sorkness C.A., King T.S., et al. Daily versus as needed corticosteroids for mild persistent asthma. N Engl J Med 352 (2005) 1519-1528
28. CAMP. The Childhood Asthma Management Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063